Bulk Manufacturer of Controlled Substances Application: Halo Pharmaceutical, Inc., 63141 [2020-22076]

Download as PDF 63141 Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices Issued: October 1, 2020. Lisa Barton, Secretary to the Commission. In accordance with 21 CFR 1301.33(a), this is notice that on September 3, 2020, Halo Pharmaceutical Inc, 30 North Jefferson Road, Whippany, New Jersey 07981, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: [FR Doc. 2020–22027 Filed 10–5–20; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Controlled substances Drug Enforcement Administration Drug codes Schedule [Docket No. DEA–727] Dihydromorphine ...... Hydromorphone ........ Bulk Manufacturer of Controlled Substances Application: Halo Pharmaceutical, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Halo Pharmaceutical, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 7, 2020. Such persons may also file a written request for a hearing on the application on or before December 7, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: 9145 9150 I II The company plans to manufacture Hydromorphone (9150) for distribution to its customers. Dihydromorphine (9145) is an intermediate in the manufacture of Hydromorphone and is not for commercial distribution. No other activity for these drug codes is authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–22076 Filed 10–5–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–726] ACTION: Notice of application. S&B Pharma, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 7, 2020. Such persons may also file a written request for a hearing on the application on or before December 7, 2020. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on August 25, 2020, S&B Pharma, LLC, 405 South Motor Avenue, Azusa, California 91702, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Bulk Manufacturer of Controlled Substances Application: S&B Pharma, LLC Drug Enforcement Administration, Justice. AGENCY: Controlled substance Drug code khammond on DSKJM1Z7X2PROD with NOTICES Gamma Hydroxybutyric Acid ........................................................................................................................................... Marihuana ........................................................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................... Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Lisdexamfetamine ............................................................................................................................................................ Methylphenidate .............................................................................................................................................................. Pentobarbital .................................................................................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) ..................................................................................................................... Tapentadol ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers. In reference to drug code 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture both as synthetic substances. No other activity for these drug codes is authorized for this registration. William T. McDermott, Assistant Administrator. 2010 7360 7370 1100 1105 1205 1724 2270 8333 9780 9801 Drug Enforcement Administration [Docket No. DEA–725] [FR Doc. 2020–22075 Filed 10–5–20; 8:45 am] Importer of Controlled Substances Application: Wildlife Laboratories, LLC BILLING CODE 4410–09–P Drug Enforcement Administration, Justice. ACTION: 17:52 Oct 05, 2020 Jkt 253001 I I I II II II II II II II II DEPARTMENT OF JUSTICE AGENCY: VerDate Sep<11>2014 Schedule PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 E:\FR\FM\06OCN1.SGM Notice of application. 06OCN1

Agencies

[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Page 63141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22076]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-727]


Bulk Manufacturer of Controlled Substances Application: Halo 
Pharmaceutical, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Halo Pharmaceutical, Inc. has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before December 7, 
2020. Such persons may also file a written request for a hearing on the 
application on or before December 7, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 3, 2020, Halo Pharmaceutical Inc, 30 North 
Jefferson Road, Whippany, New Jersey 07981, applied to be registered as 
a bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
        Controlled  substances            codes           Schedule
------------------------------------------------------------------------
Dihydromorphine.......................       9145  I
Hydromorphone.........................       9150  II
------------------------------------------------------------------------

    The company plans to manufacture Hydromorphone (9150) for 
distribution to its customers. Dihydromorphine (9145) is an 
intermediate in the manufacture of Hydromorphone and is not for 
commercial distribution. No other activity for these drug codes is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22076 Filed 10-5-20; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.